House passes bill to suspend tariffs on imported infant formula base powders
The House today passed legislation that would suspend through 2022 tariffs on certain infant formula base powders used to make infant formula in the United States. Congress in July passed legislation (H.R.8351) suspending tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Chairperson's File
This week brings the fourth week of the federal government shutdown as Congress has yet to pass legislation to fund the government. This shutdown is a bit…
Headline
The government shutdown is expected to continue into next week as the Senate is expected to adjourn Oct. 23 with no plans to vote this weekend. The chamber Oct…
Headline
The Senate Oct. 16 failed for a 10th time to advance the continuing resolution to extend government funding and end the ongoing shutdown. The chamber adjourned…
Chairperson's File
There is a saying that is very timely for our field: A smooth sea never made a skilled sailor. As we head into the final months of 2025, hospitals and health…
Headline
The federal government shutdown is expected to continue into next week as the Senate adjourned Oct. 9 after failing to pass spending legislation; senators plan…
Headline
The AHA provided a statement of record to the Senate Special Committee on Aging for a hearing Oct. 8 on the pharmaceutical and medical device supply chains.…